Publication | Open Access
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy
41
Citations
30
References
2017
Year
Our preclinical and clinical studies suggest PPARα as a novel disease-modifying target for antiepileptic drugs due to its ability to regulate dysfunctional nAChRs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1